These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30653427)

  • 41. A novel break point of the BMPR2 gene exonic deletion in a patient with pulmonary arterial hypertension.
    Aimi Y; Hirayama T; Kataoka M; Momose Y; Nishimaki S; Matsushita K; Yoshino H; Satoh T; Gamou S
    J Hum Genet; 2013 Dec; 58(12):815-8. PubMed ID: 24132125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.
    Talati MH; Brittain EL; Fessel JP; Penner N; Atkinson J; Funke M; Grueter C; Jerome WG; Freeman M; Newman JH; West J; Hemnes AR
    Am J Respir Crit Care Med; 2016 Sep; 194(6):719-28. PubMed ID: 27077479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening asymptomatic
    Morrell NW
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 34301716
    [No Abstract]   [Full Text] [Related]  

  • 44. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
    Wong WK; Knowles JA; Morse JH
    Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel BMPR2 gene mutation associated with exercise-induced pulmonary hypertension in septal defects.
    Möller T; Leren TP; Eiklid KL; Holmstrøm H; Fredriksen PM; Thaulow E
    Scand Cardiovasc J; 2010 Dec; 44(6):331-6. PubMed ID: 21070126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Signaling molecules in nonfamilial pulmonary hypertension.
    Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA
    N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylation Analysis of the BMPR2 Gene Promoter Region in Patients With Pulmonary Arterial Hypertension.
    Pousada G; Baloira A; Valverde D
    Arch Bronconeumol; 2016 Jun; 52(6):293-8. PubMed ID: 26654628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.
    Machado RD
    Eur Respir J; 2012 Feb; 39(2):235-7. PubMed ID: 22298609
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Kataoka M; Satoh T; Fukuda K
    Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
    [No Abstract]   [Full Text] [Related]  

  • 53. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Waiting in anticipation: the genetics of pulmonary arterial hypertension.
    Aldred MA; Morrell NW
    Am J Respir Crit Care Med; 2012 Nov; 186(9):820-1. PubMed ID: 23118082
    [No Abstract]   [Full Text] [Related]  

  • 55. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.
    Tatebe S; Sugimura K; Aoki T; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Satoh K; Fukuda K; Adachi O; Saito R; Nakanishi N; Morisaki H; Oyama K; Saiki Y; Okada Y; Shimokawa H
    Intern Med; 2017 Dec; 56(23):3193-3197. PubMed ID: 29021450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
    Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
    Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack.
    White RJ; Morrell NW
    Circulation; 2012 Oct; 126(15):1818-20. PubMed ID: 23044607
    [No Abstract]   [Full Text] [Related]  

  • 60. Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.
    Hamid R; Loyd J
    Eur Respir J; 2012 Jun; 39(6):1292-3. PubMed ID: 22654004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.